# Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics

> **NCT03012529** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 843 (actual)

## Conditions studied

- Osteomyelitis
- Diabetes
- Amputation

## Interventions

- **DRUG:** Rifampin
- **DRUG:** Riboflavin Placebo

## Key facts

- **NCT ID:** NCT03012529
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-22
- **Primary completion:** 2025-11-05
- **Final completion:** 2025-11-05
- **Target enrollment:** 843 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03012529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03012529, "Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03012529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*